# Polyprenols (Ropren) in Acute Coronary Syndrome

> **NCT03122340** · PHASE3 · COMPLETED · sponsor: **Tomsk National Research Medical Center of the Russian Academy of Sciences** · enrollment: 70 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Ropren
- **OTHER:** Oil

## Key facts

- **NCT ID:** NCT03122340
- **Lead sponsor:** Tomsk National Research Medical Center of the Russian Academy of Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-01
- **Primary completion:** 2017-12-31
- **Final completion:** 2018-02-28
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2018-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03122340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03122340, "Polyprenols (Ropren) in Acute Coronary Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03122340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*